Jim has over 25 years of life sciences leadership experience in business and corporate development capacities, and currently serves as Adherium’s SVP of Business Development based in the Silicon Valley region in northern California. He has successfully completed numerous transactions within the pharma/biotech sector in North America, Europe, and Asia-Pacific territories. Jim’s current responsibilities at Adherium include strategic partnering of Smartinhaler(TM) platform technologies across several industry channels including insurance companies, health network disease management systems, and the pharma industry, in addition to general market expansion in North America.
Most recently Jim served as Vice President of Business Development at Nektar Therapeutics, responsible for strategic partnerships involving late stage clinical assets in chronic pain, oncology, and ophthalmology. Before Nektar, Jim served for several years as Vice President of Business Development at Sun Pharmaceutical Industries executing numerous North American transactions and select partnerships in Japan. Jim began his career with scientific positions at Alza Corp and Abbott Labs, followed by business management positions at Eurand and Antares Pharma.
Jim received graduate and undergraduate degrees in biochemistry and neurobiology from the University of California. In addition, Jim completed post-graduate studies in financial analytics at University of Chicago GSB. Jim currently serves on the Board of Directors of Temple Therapeutics BV.